contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


zealand-pharma-to-participate-in-the-jefferies-london-healthcare-conference

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.

Zealand Pharma

Press Release – No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark, November 13, 2024 – Zealand Pharma A/S (CVR-no. 20045078), a biotechnolog...

Press Release – No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark,&nbsp;November 13, 2024&nbsp;–&nbsp;Zealand Pharma A/S (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that Chief Executive Officer, Adam Steensberg, will participate in a fireside chat at the Jefferies London Healthcare Conference at 9:30 a.m. GMT (10:30 a.m. CET) on Thursday, November 21, 2024. A live audio webcast of the fireside chat will be available at <a href="https://www.globenewswire.com/Tracker?data=mHKLEmkbDOq2XOk_8g7IUsXshWTxKa046WtETBgLjEKVs52zR5JgIMbrwwX-hvv6vaKVUMy6z6TK9s6WPgnIpI5D9BTqvD-0QTEPhsHnLwTp64sYiAJ_KE6SC1OoYf0qtTwTBsj7-aQcMuUzJiJeWxgeuAsXavHZYCTXpFHpEPY=">https://wsw.com/webcast/jeff315/zeal/1844976</a> and accessible through the company’s website at <a href="https://www.globenewswire.com/Tracker?data=mHKLEmkbDOq2XOk_8g7IUnl7BFKDg82hqgXIlFO5_BJ5TgnSPGyf_shQu8V6FkT3hE63xrfgyE2pFwh9YrOLL78ysAPDQBBlfKbqLij8rljpyenh478x5_jKHKCc6-Uqol6eUBUmnemxDO93QyUyTdn5PzFLjF6-GEBT8oCipH_U0XbeN7F4fhz3lyOAEri6fRQQPqaProFxz6OxkoqYmg==">https://www.zealandpharma.com/investors/events-presentations/</a> where a recording of the webcast will also be archived after the event. About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand’s business and activities, please visit <a href="https://www.globenewswire.com/Tracker?data=5D8Q1igKzqnMUJmq47tWJADNAZiVYvkXbV7wkz7aJfSnYC9nJ_V21dqKOvsZP2D91Z-GK-wCIz4zeAt3bz_ZLhZjPGNOE-t8ebuTti4D6X0=">www.zealandpharma.com</a>. Contacts: Anna Krassowska, PhD Vice President, Investor Relations &amp; Corporate Communications Zealand Pharma Email: <a href="https://www.globenewswire.com/Tracker?data=IIhXVIGpP3Fj_OsPWKfevm8Ek_1lxJT5tqjyauI_7MCWDWG9fS_6OcyJAT1bLgt_XYfFob5JIztlafgQiCQjy1QlkhvWk-CDQuD4sjxowTrtvHldKwpu2VFnwiYJdN3W">AKrassowska@zealandpharma.com</a> Adam Lange Investor Relations Officer Zealand Pharma Email: <a href="https://www.globenewswire.com/Tracker?data=xUWqodTrAkMwSpDf4XnNTBKZMF1DxENgcVnAL2iHEG0GhUMVQUz9ndjHQsaPDzZgC3oASOwX43Rx8y6qtIHZI2dnhk3izZtC1NXJXQGmwMMo56YlebZk1zg9H1XBbxBD">ALange@zealandpharma.com</a> Neshat Ahmadi Investor Relations Manager Zealand Pharma Email: <a href="https://www.globenewswire.com/Tracker?data=YjgJoLVh4iaRs48h9kQz5rOsJ0dTafS_j4IqzSVIK3KdU5ocBCoIZHLbisBdLzcdlMMz38DPDJc_QR98yyXvkSq5VnwtfyYco63FZm3K4OOt0K5cxdDyh1nUaAvfqoZn">NeAhmadi@zealandpharma.com</a> <img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTAxMzA1NyM0MDE5ODY0MzIjMjAwMTcwMQ=="> <img src="https://ml-eu.globenewswire.com/media/NjBlMWJiNDMtYThkYy00OWM5LWFhNWQtZWE5NWM1ZjM1ZmFkLTEwMTMyNzQ=/tiny/Zealand-Pharma.png">